Islamabad: Health authorities and the Federal Investigation Agency (FIA) on Thursday raided a private diagnostic laboratory in Islamabad’s Blue Area and recovered flu vaccines of a multinational pharmaceutical company that had not been legally imported into Pakistan, arresting the laboratory’s owner and two managers, officials said.
Officials of the Ministry of National Health Services and law enforcing agencies’ officials said the joint operation was conducted following information that a private diagnostic laboratory on Fazle Haq Road was administering imported influenza vaccines despite their official unavailability in the country.
During the raid, officials recovered influenza vaccines of European origin belonging to a multinational pharmaceutical company. Health ministry officials said the vaccines had not been imported through authorised channels and were consequently declared spurious.
The laboratory’s owner and two managers were formally arrested, while a First Information Report (FIR) was registered against them. Officials said further investigations were underway to establish how the vaccines entered Pakistan and whether they had been supplied to other healthcare facilities.
The raid comes amid a serious shortage of seasonal influenza vaccines across Pakistan, where vaccines manufactured by multinational pharmaceutical companies have remained unavailable throughout the current vaccination season.
Officials said Abbott’s Influvac and Sanofi’s Vaxigrip, two internationally recognised influenza vaccines, had not been officially imported for the 2026-27 influenza season, leaving patients dependent on limited supplies of Chinese-manufactured vaccines.
Although Chinese trivalent influenza vaccines, including Sinovac’s Anflu and Shenzhen Innovax’s Virionza, were introduced earlier this season, their availability has remained limited, with stocks exhausted at several vaccination facilities.
Pulmonologists and infectious diseases specialists said many people, particularly elderly individuals and patients suffering from chronic respiratory illnesses, diabetes and cardiovascular diseases, preferred multinational pharmaceutical companies’ vaccines because of their familiarity with these brands.
They said patients and families frequently contacted hospitals, pharmacies and vaccination centres searching for Influvac and Vaxigrip, and reports of their availability at private facilities could attract people desperate to protect themselves and their elderly relatives against influenza.
Health experts warned that vaccines obtained through unauthorised channels could pose risks because their authenticity, storage conditions and temperature-controlled transportation could not be independently verified.
Earlier, drug regulatory authorities had also reported suspected counterfeit influenza vaccines in Lahore, while the Drug Regulatory Authority of Pakistan (DRAP) issued an alert concerning counterfeit Vaxigrip Tetra vaccines.
The shortage has been compounded by delays in approving revised maximum retail prices for imported influenza vaccines, with regulatory officials previously indicating that pricing decisions were affecting fresh imports.
Public health experts said Pakistan required substantially larger quantities of influenza vaccines to protect vulnerable populations, particularly elderly people, pregnant women, healthcare workers and individuals with underlying medical conditions.
They urged authorities to ensure the availability of quality-assured influenza vaccines through authorised channels while intensifying surveillance against counterfeit and illegally supplied vaccines.
Officials said investigations into the Islamabad laboratory would also examine the procurement and distribution network behind the recovered vaccines.
